Palisade Bio, Inc. (PALI)

NASDAQ

$1,49

$-0,02

(-1,59%)

Pre-Market

Palisade Bio, Inc. (PALI) Live Price Chart

Last updated: ⁦2026-10-09 09:09:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Palisade Bio, Inc. (PALI) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $1,49, with a market capitalization of $257,92M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,32 to $2,86. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$257,92M
Open	$1,51
Day's High	$8.182,50
Day's Low	$0,53
Previous Close	$1,45
Volume	826,00
Average Volume	2,55M
P/E Ratio	--
52-Week High	$2,86
52-Week Low	$1,32
Dividend Yield	--
Earnings Date	--

Palisade Bio, Inc. (PALI) Pre-Market Stock Price

Palisade Bio, Inc. (PALI) is trading at $1,49 in pre-market trading as of 2026-10-09 08:23:00, up 2,41% ($0,04) from the previous close of $1,45

Pre-market trading shows how investors are pricing PALI before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Palisade Bio, Inc. (PALI) 7-Day Stock Price Change

Over the past seven days, Palisade Bio, Inc. (PALI) moved from $1,35 to $1,49, representing a gain of 10,00% ($0,14).

The stock traded between $1,32 and $1,55 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 2,27 million shares, down versus the previous seven-day period, indicating lower trading activity.

PALI 52-Week Price Position

Position in Range: 10,7%

52W Low$1,32

52W High$2,86

PALI is currently trading at $1,49, placing it 10,7% of the way from its 52-week low of $1,32 to its 52-week high of $2,86. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Palisade Bio, Inc. (PALI)?

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Palisade Bio, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	14
Exchange	NASDAQ
Company Website	https://www.palisadebio.com

How to Buy Palisade Bio, Inc. (PALI) Stock on MEXC

Eligible investors can buy real shares of Palisade Bio, Inc. (PALI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PALI and Place Your Order

Open the RealStocks trading page and search for PALI. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Palisade Bio, Inc. (PALI) stock price today?

Palisade Bio, Inc. (PALI) is currently trading at $ 1,49, up 2,41% ($0,04) from the previous close of $ 1,45. Intraday prices update in real time during regular trading hours.

2.Is PALI stock going up or down today?

As of 2026-10-09 08:23:00, PALI is trading at $ 1,49, up 2,41% ($0,04) from its previous close of $ 1,45. The stock has traded between $ 0,53 and $ 8.182,50 during today’s regular session. Past price movements do not guarantee future results.

3.What is PALI pre-market price?

As of 2026-10-09 08:23:00, PALI is trading at $ 1,49 in pre-market trading, up 2,41% ($0,04) from the previous close of $ 1,45. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PALI after-hours price?

As of 2026-10-09 08:23:00, PALI is trading at $ 1,51 in after-hours trading, up 3,79% ($0,05) from the regular-session close of $ 1,45. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is PALI stock trading now?

PALI trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PALI sit relative to its 52-week high and low?

Over the past 52 weeks, PALI has traded between a low of $ 1,32 and a high of $ 2,86. At $ 1,49, the stock is positioned 10,7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Palisade Bio, Inc. in?

Palisade Bio, Inc. (PALI) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Palisade Bio, Inc.'s market capitalization and where is it listed?

Palisade Bio, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 257,92M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PALI valued in terms of P/E ratio and EPS?

PALI trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0,18. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Palisade Bio, Inc. pay a dividend?

Palisade Bio, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.